NOVEMBER SALE - 20% OFF Everything!Shop Now
SLU-PP-332 - 250mcg / Capsule
99.31% HPLC purityLot-tested · COA below

SLU-PP-332

$149.00each · 250mcg / Capsule

4.7· 3 reviewsout of 5In stock

60 Capsules / Bottle

Buy SLU-PP-332 research capsules, 250 mcg x 60 per bottle. Synthetic pan-ERR agonist, 99.31% purity by UHPLC-MS with a public COA. Ships in 24 hours.

Regular price $186.00Sale price $149.00You save $37.00 (20%)
1

Bundle & Save

Need more?

Select and SubscribeSave 20%
Order within 20h 39m to ship Mon, Nov 23Cutoff 5:00 PM PST · ships next business day
U.S. delivery availableFree shipping on orders over $150.00
Reship policyWrong item sent? We reship it free. Transit issues reviewed case by case.

Secure checkout · Visa · Mastercard · American Express · Discover · PayPal · Venmo · Apple Pay

Test results · tested sample

99.31%

Reported purity · Tested by Bioregen

Tested
Jul 18, 2025
Labeled
250mcg / Capsule
Lab
Bioregen
View certificate (PDF) →

Product details

SLU-PP-332, in brief. Muscle cells carry a set of switches called estrogen-related receptors (ERRs) that turn on the genes for burning fat and building mitochondria, the same genes that endurance exercise turns on. SLU-PP-332 is a small synthetic molecule, made at Saint Louis University, that flips those switches directly. It is not a peptide and has nothing to do with estrogen despite the receptor name. In mice it raised energy use, shifted muscle toward oxidative fibers and extended treadmill running by about 70% without any training [1]. In obese mice it cut fat gain about tenfold and the treated mice lost about 12% of their body weight over a month, with no change in food intake [3,4]. No clinical trial of SLU-PP-332 has been published or registered. NextGenPeps supplies SLU-PP-332 as 250 mcg capsules, 60 per bottle, for laboratory use only.

What does SLU-PP-332 do?

It makes muscle behave as if it had been trained for endurance. SLU-PP-332 activates the ERR family of nuclear receptors, which control the genes for mitochondria and fat burning, and in mice that was enough to change both how the muscle is built and how far the animals could run [1].

In practice that means three things in animal and cell models:

  • More mitochondria. Treated mouse muscle had more mitochondria, more mitochondrial DNA and more respiratory chain protein, and cultured muscle cells respired harder [1].

  • More oxidative muscle fibers. Treated mice gained type IIa fibers, the fatigue-resistant fast oxidative type, and ran longer and further on a treadmill [1].

  • More energy spent. Obese mice burned more energy and more fat while eating the same amount, and gained far less fat than untreated controls [3,4].

NextGenPeps supplies SLU-PP-332 for in vitro research and approved animal studies only. It is not sold as a drug, supplement, diagnostic or performance product.

How does SLU-PP-332 work?

It is a pan-agonist of the three estrogen-related receptors, ERRα, ERRβ and ERRγ, with the strongest pull on ERRα.

ERRs are nuclear receptors: proteins that sit on DNA and switch groups of genes on or off. They share part of their name with the estrogen receptor but do not bind estrogen. ERRα in particular drives the genes for mitochondrial biogenesis, oxidative phosphorylation and fatty acid oxidation. In full-length receptor assays SLU-PP-332 reached half-maximal activation at 98 nM for ERRα, 230 nM for ERRβ and 430 nM for ERRγ, about 4.4-fold selectivity for ERRα over ERRγ (Figure 2) [2]. Chemically it is an analogue of the older tool compound GSK4716, with a naphthalene ring in place of an isopropylphenyl group [2].

Within an hour in mouse muscle it switched on part of the gene program that a single bout of aerobic exercise switches on, including Ddit4 (about 3-fold) and Slc25a25 (about 11-fold) [2]. That response needed ERRα: it was lost in muscle cells lacking ERRα, and mice with ERRα deleted from muscle gained no endurance from the compound [1,2].

Flow diagram: SLU-PP-332 activates the nuclear receptors ERR alpha, beta and gamma, strongest at ERR alpha with an EC50 of 98 nM, which switch on target genes such as Ddit4 and Slc25a25, leading to more mitochondria, more type IIa oxidative fibers and more fat burned.

Figure 1. How SLU-PP-332 switches on an exercise-like program. A simplified view of the pathway reported in mouse muscle and C2C12 muscle cells. Source: Billon et al., ACS Chem Biol 2023 and J Pharmacol Exp Ther 2024 [1,3].

Horizontal bar chart of SLU-PP-332 EC50 values: 98 nM at ERR alpha, 230 nM at ERR beta and 430 nM at ERR gamma, about 4.4-fold more potent at ERR alpha than ERR gamma.

Figure 2. SLU-PP-332 potency at the three ERRs. Half-maximal activation of full-length receptors in a cell reporter assay; lower is more potent. Source: Billon et al., bioRxiv 2022, published in ACS Chem Biol 2023 [1,2]. Values are assay-specific.

What did SLU-PP-332 do in animal studies?

The mice ran further and stayed leaner. Those are the two results that made the compound known, and both come from the group that developed it.

Endurance. Young male C57BL/6J mice given SLU-PP-332 by injection for about a week ran about 70% longer and about 45% further on a treadmill to exhaustion than vehicle-treated mice (n=6 per group), with no exercise training [1,2]. Their muscle showed more type IIa fibers, more mitochondria and higher succinate dehydrogenase staining, a marker of oxidative capacity [2].

Obesity. Diet-induced obese mice treated twice a day for about a month gained about ten times less fat than untreated mice and lost about 12% of their own body weight, while eating the same amount of food and without moving more [3,4]. The paper also reports higher energy expenditure and fatty acid oxidation, and better insulin sensitivity, in diet-induced obese and leptin-deficient ob/ob mice [3].

Heart and kidney. In mice with pressure-overload heart failure, SLU-PP-332 and a second ERR agonist improved ejection fraction, reduced fibrosis and increased survival without changing heart enlargement; ERRγ carried most of that effect [5]. In 21-month-old mice, eight weeks of treatment reversed age-related albuminuria, podocyte loss, mitochondrial dysfunction and kidney inflammation [6].

Bar chart with vehicle set to 100: in lean mice SLU-PP-332 raised treadmill running time to about 170 and distance to about 145; in diet-induced obese mice fat gained fell to about 10. A separate panel shows treated obese mice lost about 12% of their own body weight over about a month.

Figure 3. What happened to the mice. Bars: vehicle set to 100 for running time, running distance and fat gained. The separate body weight panel shows the treated obese mice's own weight change (about 12% lost over about a month), not a comparison with vehicle. Endurance from lean mice after about a week of treatment; fat gain and body weight from diet-induced obese mice. Sources: Billon et al., ACS Chem Biol 2023 and J Pharmacol Exp Ther 2024 [1,3,4]. The studies shown used injected compound, not oral capsules.

SLU-PP-332 vs SLU-PP-915

Both are pan-ERR agonists from the same research program, but they are structurally different molecules [5]. SLU-PP-332 is the original, published compound with the endurance, obesity, heart and kidney data above. SLU-PP-915 is a structurally distinct agonist tested alongside it in the heart failure model, where both compounds improved cardiac function [5]. Results from one should not be assumed for the other.

What is SLU-PP-332 made of?

It is a small organic molecule, not a peptide: no amino acids, no sequence, and a molecular weight under 300.

SLU-PP-332 is an acylhydrazone. A 4-hydroxybenzoyl group is joined through a hydrazone link (C(=O)NH-N=CH) to a naphthalene ring. It is made by condensing 2-naphthaldehyde with 4-hydroxybenzohydrazide [2]. The formula is C18H14N2O2 and the molecular weight is 290.32 g/mol [8].

SLU-PP-332 at a glance

  • Compound: SLU-PP-332, (E)-4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide [2]

  • Class: Synthetic small molecule; pan-agonist of estrogen-related receptors ERRα, ERRβ and ERRγ. Not a peptide

  • Structure: Acylhydrazone linking a 4-hydroxyphenyl group to a naphthalene ring; CAS 303760-60-3; PubChem CID 5404083 [8]

  • Molecular formula and weight: C18H14N2O2, 290.32 g/mol [8]

  • Strength: 250 mcg per capsule, 60 capsules per bottle (15 mg per bottle)

  • Identity and purity: 99.31% by UHPLC with mass spectrometry on the current lot (July 18, 2025), tested by an independent lab; the certificate is published in the COA library

  • Appearance: Capsules in a sealed bottle

  • Potency: EC50 98 nM (ERRα), 230 nM (ERRβ), 430 nM (ERRγ) in full-length receptor assays [2]

  • Regulatory status: Not an approved drug anywhere; no clinical trials published or registered. Research use only

Is SLU-PP-332 legal or FDA approved?

It is not FDA approved, and it has never been tested in a clinical trial. SLU-PP-332 is an experimental research compound: all published efficacy data come from mice and cultured cells [1,3,5,6]. The developing group described it in 2023 as being at an early stage, with structural refinement and further animal safety work still ahead of any clinical testing [4]. NextGenPeps sells it only as a research chemical for in vitro and approved animal work.

What is SLU-PP-332 used to study?

Researchers use it as a chemical switch for ERR signalling, to ask what happens when the exercise gene program is turned on without exercise.

  • Exercise mimetics. Endurance, fiber-type switching and mitochondrial biogenesis in sedentary mice, and how much of the exercise response runs through ERRα [1].

  • Obesity and metabolic syndrome. Fat mass, energy expenditure, fatty acid oxidation and insulin sensitivity in diet-induced obese and ob/ob mice [3].

  • Heart failure. Cardiac fatty acid metabolism and mitochondrial function in pressure-overload models, where ERRγ is the main mediator [5].

  • Kidney aging. Mitochondrial dysfunction and inflammation through the cGAS-STING and STAT3 pathways in aged mouse kidney [6].

  • Muscle cell aging. In primary myoblasts cultured from biopsies of physically inactive donors, 10 µM SLU-PP-332 for 48 hours lowered reactive oxygen species by 37.7%, raised glutathione by 117.4% and improved myotube formation [7].

Buying SLU-PP-332 for research: what each bottle includes

Every lot is tested by independent labs and the certificate of analysis is published in the NextGenPeps COA library. The current lot was analysed by UHPLC with mass spectrometry for identity and content, at 99.31% purity.

  • Verified identity and purity. 99.31% by UHPLC-MS on the current lot; the certificate is published in the COA library.

  • Defined content. 250 mcg of SLU-PP-332 per capsule, 60 capsules per bottle.

  • US-based fulfilment. Orders ship within 24 hours from the United States, with free US shipping on orders over $150.

  • Research use only. SLU-PP-332 is sold strictly for in vitro and approved animal research. It is not for human or veterinary use and is not sold as a drug, supplement, diagnostic or performance product.

SLU-PP-332 handling, storage and analytical notes

Format. Supplied as capsules in a sealed bottle, 250 mcg per capsule. No dosing instructions are supplied, and none should be taken from the studies above, which used injected compound at doses set per kilogram.

Storage. Keep the bottle tightly closed, dry and protected from light, at 2 to 8 °C, the condition recorded on the lot's certificate. Avoid humid storage and leaving the bottle open.

Solubility. SLU-PP-332 is hydrophobic (computed XLogP 3.7) and poorly soluble in water; in vitro work typically dissolves it in DMSO [8].

Naming. "SLU" stands for Saint Louis University. SLU-PP-332 is distinct from SLU-PP-915, a later ERR agonist, and from GSK4716, the older ERR tool compound it was derived from. Despite frequent use of the word online, it is not a peptide.

What is not established about SLU-PP-332

  • Clinical data. No clinical trial has been published or registered, so there are no clinical safety or efficacy data.

  • Oral exposure. The published endurance, obesity and heart studies gave SLU-PP-332 by injection. How well it is absorbed when given orally has not been established in published work.

  • Independent replication. The endurance and obesity results come from the group that developed the compound [1,3]; independent replication is limited.

  • Long-term effects. The longest published treatment is eight weeks, in aged mice [6]. Effects of longer ERR activation are unknown.


Research Use Only. The statements made within this website have not been evaluated by the US Food and Drug Administration. These materials are not intended to diagnose, treat, cure or prevent any disease and are not intended for human or veterinary use. Studies described on this page are reported for scientific context and are not guidance of any kind.

Published research

Obesity and metabolic syndrome

In diet-induced obese mice, about a month of treatment cut fat gain about tenfold compared with untreated mice, and the treated mice lost about 12% of their own body weight, with unchanged food intake, alongside higher energy expenditure and better insulin sensitivity.

A Synthetic ERR Agonist Alleviates Metabolic Syndrome →

Compound information

Molecular class
Synthetic small molecule (acylhydrazone); pan-agonist of ERRα, ERRβ and ERRγ. Not a peptide
Chemical name
(E)-4-hydroxy-N'-(naphthalen-2-ylmethylene)benzohydrazide
Molecular formula
C₁₈H₁₄N₂O₂
Molecular weight
290.32 g/mol
CAS number
303760-60-3
Potency (EC50)
ERRα 98 nM, ERRβ 230 nM, ERRγ 430 nM (full-length receptor reporter assays)
Computed descriptors
XLogP 3.7; H-bond donors 2; H-bond acceptors 3; rotatable bonds 3 (PubChem)
Strength
250 mcg per capsule, 60 capsules per bottle (15 mg per bottle)
Physical form
Capsules, sealed bottle
Purity
99.31% by UHPLC-MS (independent lab, July 18, 2025); certificate in the COA library
Regulatory status
Research use only. Not an approved drug; no clinical trials

Storage & stability

  • Capsules in a sealed bottle
  • Keep tightly closed, dry and protected from light
  • Avoid repeated exposure to humidity and heat
Sealed bottle
2 to 8 °C, dry, protected from light (condition recorded on the lot certificate)
After opening
Reclose tightly; avoid humidity and heat
Solubility (in vitro)
Poorly water-soluble; DMSO is the usual solvent
Quantitation
250 mcg per capsule; verify content against an in-house reference

Cited literature

  1. 01
    Synthetic ERRα/β/γ agonist induces an ERRα-dependent acute aerobic exercise response and enhances exercise capacity

    Billon C, Sitaula S, Banerjee S, et al. · ACS Chem Biol 2023 · PubMed · DOI · Free full text

    Describes SLU-PP-332 as a pan-ERR agonist strongest at ERRα; in mice it increased type IIa fibers and exercise endurance, and the endurance gain required muscle ERRα. Small groups, all from the developing lab.

  2. 02
    A synthetic ERRα agonist induces an acute aerobic exercise response and enhances exercise capacity (preprint)

    Billon C, Sitaula S, Banerjee S, et al. · bioRxiv 2022 · DOI · Free full text

    Preprint of reference 1 with full methods: EC50 98, 230 and 430 nM at full-length ERRα, β and γ; ~70% longer and ~45% further running (n=6); synthesis route. Doses stated inconsistently between sections.

  3. 03
    A synthetic ERR agonist alleviates metabolic syndrome

    Billon C, Schoepke E, Avdagic A, et al. · J Pharmacol Exp Ther 2024 · PubMed · DOI · Free full text

    In diet-induced obese and ob/ob mice, SLU-PP-332 increased energy expenditure and fatty acid oxidation, reduced fat mass and improved insulin sensitivity. Injected compound, mouse only.

  4. 04
    Exercise-mimicking drug sheds weight, boosts muscle activity in mice

    University of Florida · EurekAlert! news release 2023

    Developers' summary of reference 3: obese mice treated twice daily for a month gained about ten times less fat and lost 12% of body weight with unchanged food intake; no clinical testing yet. A press release, not peer reviewed.

  5. 05
    Novel pan-ERR agonists ameliorate heart failure through enhancing cardiac fatty acid metabolism and mitochondrial function

    Xu W, Billon C, Li H, et al. · Circulation 2024 · PubMed · DOI

    SLU-PP-332 and SLU-PP-915 improved ejection fraction, reduced fibrosis and increased survival in pressure-overload heart failure in mice, mainly via ERRγ. Single surgical model.

  6. 06
    Estrogen-related receptor agonism reverses mitochondrial dysfunction and inflammation in the aging kidney

    Wang XX, Myakala K, Libby AE, et al. · Am J Pathol 2023 · PubMed · DOI · Free full text

    Eight weeks of SLU-PP-332 in 21-month-old mice reversed age-related albuminuria, podocyte loss, mitochondrial dysfunction and inflammation via cGAS-STING and STAT3. Aged mice only.

  7. 07
    Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study

    Bonanni R, Falvino A, Matticari A, et al. · Front Physiol 2025 · DOI · Free full text

    Primary myoblasts from inactive donors treated with 10 µM SLU-PP-332 for 48 h showed 37.7% lower ROS, 117.4% higher glutathione and better myotube formation. Cell culture pilot, 20 donors.

  8. 08
    SLU-PP-332 (CID 5404083)

    National Center for Biotechnology Information · PubChem

    Compound record: formula C18H14N2O2, molecular weight 290.32 g/mol, CAS 303760-60-3 and computed descriptors. Database entry, not a study.

Frequently asked questions

How is SLU-PP-332 (250mcg) packaged?

SLU-PP-332 (250mcg) is supplied in the product format and quantity shown for the selected variant. Please inspect the sealed package when it arrives and contact support promptly if the package or labeling appears damaged.

How is SLU-PP-332 (250mcg) shipped?

Orders are shipped within the United States via USPS. Transit times are typically 3–7 business days, depending on destination and carrier conditions. Tracking information is provided when available.

How should SLU-PP-332 (250mcg) be stored?

Storage requirements are product-specific. Keep SLU-PP-332 (250mcg) in its original labeled container and follow the product documentation or manufacturer instructions supplied with the order. Contact support if the applicable storage guidance is not available.

What is the refund policy for SLU-PP-332 (250mcg)?

Due to the nature of research materials, NextGenPeps orders are final and are not eligible for refunds, returns, or exchanges. Review the shipping and reship policies before ordering.

Is SLU-PP-332 (250mcg) intended for human use?

No. NextGenPeps materials are supplied strictly for laboratory research and development use and are not intended for human or animal consumption, clinical use, diagnostic use, cosmetic use, or dietary use.

Customer reviews

4.7out of 5 · 3 reviews

Research Level Quality

The consistency is outstanding, purity matches the percentage listed on the COA to the decimal across 3 separate lots.

Ashton T.

Helpful Support Team

I had trouble checking out using my PayPal but the support team was able to walk me through it and get it settled.

Vivian B.

Large inventory

The largest variety of peptides ive seen from any vendor, as well as the only one to stay consistently stocked.

Anthony E.

Common research questions

What is SLU-PP-332?

SLU-PP-332 is a synthetic small molecule developed at Saint Louis University that activates the estrogen-related receptors ERRα, ERRβ and ERRγ, most strongly ERRα. These nuclear receptors control the genes for mitochondria and fat burning that endurance exercise switches on. It is used in cell and animal research as an exercise mimetic. It is not an approved drug and has not been tested in clinical trials.

Is SLU-PP-332 a peptide?

No. SLU-PP-332 is a small organic molecule (C18H14N2O2, 290.32 g/mol), an acylhydrazone built from a hydroxyphenyl group and a naphthalene ring. It contains no amino acids. It is often listed alongside research peptides, but chemically it belongs with small-molecule receptor ligands.

What does SLU-PP-332 do in mice?

In young mice it increased oxidative type IIa muscle fibers and mitochondria, and treated mice ran about 70% longer and 45% further on a treadmill than controls without any training. The endurance gain disappeared in mice lacking ERRα in muscle. These results come from injected compound in small groups.

Does SLU-PP-332 cause weight loss in animal studies?

In diet-induced obese mice treated twice a day for about a month, SLU-PP-332 cut fat gain about tenfold compared with untreated mice, and the treated mice lost about 12% of their own body weight. Food intake did not change; the mice spent more energy and burned more fat. Insulin sensitivity also improved in obese and ob/ob mice. No such data exist outside animal models.

Has SLU-PP-332 been tested in clinical trials?

No. No clinical trial of SLU-PP-332 has been published or registered. Its published data come from mice, cultured muscle cells and cell assays. The developing group has described further chemical refinement and animal safety testing as the next steps.

How is SLU-PP-332 different from SLU-PP-915?

Both are pan-ERR agonists from the same research program, but they are structurally different molecules. SLU-PP-332 is the original compound behind the endurance, obesity, heart and kidney studies. SLU-PP-915 is a separate agonist that was tested alongside it in a mouse heart failure model, where both improved cardiac function. Data from one should not be assumed for the other.

Frequently Researched with

GLOW

✓ 99.71% purity

GLOW

$134.00$107.00

MOTS-C

✓ 99.79% purity

MOTS-C

$52.00$42.00

NAD+

✓ 99.81% purity

NAD+

$98.00$78.00

You have an unfinished subscription checkout

Continue your saved checkout, or replace its item with . Your saved selection and existing subscriptions will stay unchanged.

Continue saved checkout
NextGenPeps

Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.

Customer Service: +1 (971) 300-1435

Get 10% Off Your First Order

Sign up now and receive a 10% discount code valid on your next purchase!

Nextgenpeps LLC

The statements made within this website have not been evaluated by the US Food and Drug Administration. The materials offered by this company are not intended to diagnose, treat, cure, or prevent any disease. All research materials on this site are for laboratory research and development use only, and are not intended for human use.

NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

Privacy PolicyTerms & ConditionsAffiliate Program

501 W Broadway Ste A, San Diego, CA 92101

© 2026 NextGenPeps. All rights reserved.

Visa
American Express
Mastercard
PayPal
Discover
Apple Pay